v1
Oral administration of imatinib to P230 BCR/ABL-expressing transgenic mice changes clones with high BCR/ABL complementary DNA expression into those with low expression.
- NobleID
- NI2P94W47R97S03
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/C0CD1B28
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims